Amrize Ltd $AMRZ Shares Sold by Allianz Asset Management GmbH

Allianz Asset Management GmbH lessened its holdings in shares of Amrize Ltd (NYSE:AMRZ) by 49.6% during the third quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The firm owned 1,605,508 shares of the company’s stock after selling 1,582,603 shares during the period. Allianz Asset Management GmbH’s holdings in Amrize were worth $77,469,000 as of its most recent SEC filing.

Several other institutional investors and hedge funds also recently added to or reduced their stakes in AMRZ. State of Wyoming acquired a new stake in shares of Amrize in the 3rd quarter worth approximately $32,000. Global Retirement Partners LLC acquired a new position in shares of Amrize in the third quarter worth $48,000. Jones Financial Companies Lllp acquired a new position in Amrize in the 3rd quarter valued at about $53,000. BNP Paribas Financial Markets purchased a new position in Amrize in the 2nd quarter valued at about $59,000. Finally, Groupe la Francaise acquired a new stake in shares of Amrize during the 2nd quarter worth about $60,000.

Insider Activity

In other news, Director Nicholas C. Gangestad acquired 2,000 shares of the company’s stock in a transaction dated Wednesday, November 19th. The stock was acquired at an average cost of $47.34 per share, for a total transaction of $94,680.00. Following the acquisition, the director directly owned 4,958 shares in the company, valued at approximately $234,711.72. This represents a 67.61% increase in their position. The purchase was disclosed in a legal filing with the SEC, which is available at this link.

Amrize Stock Performance

Shares of AMRZ stock opened at $53.95 on Wednesday. The company has a quick ratio of 0.97, a current ratio of 1.45 and a debt-to-equity ratio of 0.38. The firm has a market capitalization of $29.84 billion and a price-to-earnings ratio of 29.32. Amrize Ltd has a one year low of $44.12 and a one year high of $58.11. The stock’s 50 day moving average is $54.38.

Wall Street Analysts Forecast Growth

A number of equities research analysts have recently commented on AMRZ shares. Morgan Stanley set a $61.00 price objective on shares of Amrize and gave the company an “overweight” rating in a research report on Wednesday, October 29th. Citigroup lifted their target price on shares of Amrize from $63.00 to $67.00 and gave the stock a “buy” rating in a research note on Thursday, January 8th. Vertical Research initiated coverage on Amrize in a report on Tuesday, November 25th. They issued a “hold” rating and a $54.00 price target for the company. Royal Bank Of Canada cut Amrize from an “outperform” rating to a “sector perform” rating and raised their price objective for the stock from $56.00 to $60.00 in a report on Monday, December 8th. Finally, Oppenheimer lifted their price objective on Amrize from $62.00 to $64.00 and gave the company an “outperform” rating in a research report on Thursday, January 15th. One investment analyst has rated the stock with a Strong Buy rating, seven have assigned a Buy rating and seven have given a Hold rating to the company. According to MarketBeat, the company currently has an average rating of “Moderate Buy” and an average price target of $60.75.

Amrize Company Profile

Amrize AG focuses on building materials business in North America. The company was incorporated in 2023 and is based in Zug, Switzerland. Amrize AG operates independently of Holcim AG as of June 23, 2025.